Beyond ISGlylation: Functions of Free Intracellular and Extracellular ISG15

Journal of Interferon and Cytokine Research

Volumn 37, Issue 6, 2017, Pages 246-253

  Dos Santos, Paula Fernandes ^a   Mansur, Daniel Santos ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

immunomodulation; ISG15; ISGylation

Indexed keywords

GAMMA INTERFERON; ISG15 PROTEIN; PEPTIDES AND PROTEINS; UBIQUITIN; UNCLASSIFIED DRUG; CYTOKINE; INTERFERON; INTERFERON REGULATORY FACTOR 3; IRF3 PROTEIN, HUMAN; ISG15 PROTEIN, HUMAN; PROTEIN KINASE R;

CELL ACTIVATION; CELLULAR SECRETION; CYTOKINE PRODUCTION; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; INTRACELLULAR SIGNALING; ISGYLATION; LYMPHOCYTE; MONOCYTE; NEUTROPHIL; PLASMABLAST; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN MODIFICATION; REVIEW; BACTERIAL INFECTION; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; MICROBIOLOGY; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VIROLOGY; VIRUS INFECTION;

BACTERIAL INFECTIONS; CYTOKINES; EIF-2 KINASE; GENE EXPRESSION REGULATION; HUMANS; INTERFERON REGULATORY FACTOR-3; INTERFERON TYPE I; INTERFERON-GAMMA; MONOCYTES; NEUTROPHILS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; UBIQUITINS; VIRUS DISEASES;

EID: 85020199231     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2016.0103     Document Type: Review

References (91)

1. Andersen JB, Hassel BA. 2006. The interferon regulated ubiquitin-like protein, ISG15, in tumorigenesis: friend or foe? Cytokine Growth Factor Rev 17(6):411-421.
2. Auron PE, Webb AC, Rosenwasser LJ, Mucci SF, Rich A, Wolff SM, Dinarello CA. 1984. Nucleotide sequence of human monocyte interleukin 1 precursor cDNA. Proc Natl Acad Sci USA 81(24):7907-7911.
3. Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Ortmann WA, Espe KJ, Shark KB, Grande WJ, Hughes KM, Kapur V, Gregersen PK, Behrens TW. 2003. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci USA 100(5):2610-2615.
4. Bektas N, Noetzel E, Veeck J, Press MF, Kristiansen G, Naami A, Hartmann A, Dimmler A, Beckmann MW, Knuchel R, Fasching PA, Dahl E. 2008. The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer. Breast Cancer Res 10(4):R58.
5. Bennett L, Palucka AK, Arce E, Cantrell V, Borvak J, Ban-chereau J, Pascual V. 2003. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 197(6):711-723.
6. Bieging KT, Mello SS, Attardi LD. 2014. Unravelling mechanisms of p53-mediated tumour suppression. Nat Rev Cancer 14(5):359-370.
7. Blomstrom DC, Fahey D, Kutny R, Korant BD, Knight E, Jr. 1986. Molecular characterization of the interferon-induced 15-kDa protein. Molecular cloning and nucleotide and amino acid sequence. J Biol Chem 261(19):8811-8816.
8. Bogunovic D, Byun M, Durfee LA, Abhyankar A, Sanal O, Mansouri D, Salem S, Radovanovic I, Grant AV, Adimi P, Mansouri N, Okada S, Bryant VL, Kong XF, Kreins A, Velez MM, Boisson B, Khalilzadeh S, Ozcelik U, Darazam IA, Schoggins JW, Rice CM, Al-Muhsen S, Behr M, Vogt G, Puel A, Bustamante J, Gros P, Huibregtse JM, Abel L, Boisson-Dupuis S, Casanova JL. 2012. Mycobacterial disease and impaired IFN-gamma immunity in humans with inherited ISG15 deficiency. Science 337(6102):1684-1688.
9. Burks J, Reed RE, Desai SD. 2015. Free ISG15 triggers an antitumor immune response against breast cancer: a new perspective. Oncotarget 6(9):7221-7231.
10. Care MA, Stephenson SJ, Barnes NA, Fan I, Zougman A, El-Sherbiny YM, Vital EM, Westhead DR, Tooze RM, Doody GM. 2016. Network Analysis Identifies Proinflammatory Plasma Cell Polarization for Secretion of ISG15 in Human Autoimmunity. J Immunol 197(4):1447-1459.
11. D'Cunha J, Knight E, Jr., Haas AL, Truitt RL, Borden EC. 1996a. Immunoregulatory properties of ISG15, an interferon-induced cytokine. Proc Natl Acad Sci USA 93(1):211-215.
12. D'Cunha J, Ramanujam S, Wagner RJ, Witt PL, Knight E, Jr., Borden EC. 1996b. In vitro and in vivo secretion of human ISG15, an IFN-induced immunomodulatory cytokine. J Immunol 157(9):4100-4108.
13. Dastur A, Beaudenon S, Kelley M, Krug RM, Huibregtse JM. 2006. Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation of ISG15 in human cells. J Biol Chem 281(7):4334-4338.
14. de Veer MJ, Holko M, Frevel M, Walker E, Der S, Paranjape JM, Silverman RH, Williams BR. 2001. Functional classification of interferon-stimulated genes identified using micro-Arrays. J Leukoc Biol 69(6):912-920.
15. Der SD, Zhou A, Williams BR, Silverman RH. 1998. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci USA 95(26):15623-15628.
16. Desai SD, Haas AL, Wood LM, Tsai YC, Pestka S, Rubin EH, Saleem A, Nur EKA, Liu LF. 2006. Elevated expression of ISG15 in tumor cells interferes with the ubiquitin/26S pro-teasome pathway. Cancer Res 66(2):921-928.
17. Desai SD, Reed RE, Burks J, Wood LM, Pullikuth AK, Haas AL, Liu LF, Breslin JW, Meiners S, Sankar S. 2012. ISG15 disrupts cytoskeletal architecture and promotes motility in human breast cancer cells. Exp Biol Med (Maywood) 237(1):38-49.
18. Desai SD, Wood LM, Tsai YC, Hsieh TS, Marks JR, Scott GL, Giovanella BC, Liu LF. 2008. ISG15 as a novel tumor bio-marker for drug sensitivity. Mol Cancer Ther 7(6):1430-1439.
19. Eskildsen S, Justesen J, Schierup MH, Hartmann R. 2003. Characterization of the 2'-5'-oligoadenylate synthetase ubiquitin-like family. Nucleic Acids Res 31(12):3166-3173.
20. Farrell PJ, Broeze RJ, Lengyel P. 1979. Accumulation of an mRNA and protein in interferon-treated Ehrlich ascites tumour cells. Nature 279(5713):523-525.
21. Feng X, Wu H, Grossman JM, Hanvivadhanakul P, FitzGerald JD, Park GS, Dong X, Chen W, Kim MH, Weng HH, Furst DE, Gorn A, McMahon M, Taylor M, Brahn E, Hahn BH, Tsao BP. 2006. Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus. Arthritis Rheum 54(9):2951-2962.
22. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. 1993. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 178(6):2249-2254.
23. Francois-Newton V, Livingstone M, Payelle-Brogard B, Uze G, Pellegrini S. 2012. USP18 establishes the transcriptional and anti-proliferative interferon alpha/beta differential. Biochem J 446(3):509-516.
24. Franklin BS, Bossaller L, De Nardo D, Ratter JM, Stutz A, Engels G, Brenker C, Nordhoff M, Mirandola SR, Al-Amoudi A, Mangan MS, Zimmer S, Monks BG, Fricke M, Schmidt RE, Espevik T, Jones B, Jarnicki AG, Hansbro PM, Busto P, Marshak-Rothstein A, Hornemann S, Aguzzi A, Kastenmuller W, Latz E. 2014. The adaptor ASC has extra-cellular and 'prionoid' activities that propagate inflammation. Nat Immunol 15(8):727-737.
25. Giannakopoulos NV, Arutyunova E, Lai C, Lenschow DJ, Haas AL, Virgin HW. 2009. ISG15 Arg151 and the ISG15-conjugating enzyme UbE1 L are important for innate immune control of Sindbis virus. J Virol 83(4):1602-1610.
26. Giannakopoulos NV, Luo JK, Papov V, Zou W, Lenschow DJ, Jacobs BS, Borden EC, Li J, Virgin HW, Zhang DE. 2005. Proteomic identification of proteins conjugated to ISG15 in mouse and human cells. Biochem Biophys Res Commun 336(2):496-506.
27. Guerra S, Caceres A, Knobeloch KP, Horak I, Esteban M. 2008. Vaccinia virus E3 protein prevents the antiviral action of ISG15. PLoS Pathog 4(7):e1000096.
28. Haas AL, Ahrens P, Bright PM, Ankel H. 1987. Interferon induces a 15-kilodalton protein exhibiting marked homology to ubiquitin. J Biol Chem 262(23):11315-11323.
29. Hare NJ, Chan B, Chan E, Kaufman KL, Britton WJ, Saunders BM. 2015. Microparticles released from Mycobacterium tuberculosis-infected human macrophages contain increased levels of the type I interferon inducible proteins including ISG15. Proteomics 15(17):3020-3029.
30. Hoan NX, Van Tong H, Giang DP, Toan NL, Meyer CG, Bock CT, Kremsner PG, Song LH, Velavan TP. 2016. Interferon-stimulated gene 15 in hepatitis B-related liver diseases. On-cotarget.
31. Hogquist KA, Unanue ER, Chaplin DD. 1991. Release of IL-1 from mononuclear phagocytes. J Immunol 147(7):2181-2186.
32. Huang YF, Wee S, Gunaratne J, Lane DP, Bulavin DV. 2014. Isg15 controls p53 stability and functions. Cell Cycle 13(14):2200-2210.
33. Jeon YJ, Choi JS, Lee JY, Yu KR, Ka SH, Cho Y, Choi EJ, Baek SH, Seol JH, Park D, Bang OS, Chung CH. 2008. Fi-lamin B serves as a molecular scaffold for type I interferon-induced c-Jun NH2-terminal kinase signaling pathway. Mol Biol Cell 19(12):5116-5130.
34. Jeon YJ, Choi JS, Lee JY, Yu KR, Kim SM, Ka SH, Oh KH, Kim KI, Zhang DE, Bang OS, Chung CH. 2009. ISG15 modification of filamin B negatively regulates the type I interferon-induced JNK signalling pathway. EMBO Rep 10(4):374-380.
35. Kiessling A, Hogrefe C, Erb S, Bobach C, Fuessel S, Wessjo-hann L, Seliger B. 2009. Expression, regulation and function of the ISGylation system in prostate cancer. Oncogene 28(28):2606-2620.
36. Kim MJ, Hwang SY, Imaizumi T, Yoo JY. 2008. Negative feedback regulation of RIG-I-mediated antiviral signaling by interferon-induced ISG15 conjugation. J Virol 82(3):1474-1483.
37. Kirou KA, Lee C, George S, Louca K, Peterson MG, Crow MK. 2005. Activation of the interferon-Alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Arthritis Rheum 52(5):1491-1503.
38. Knight E, Jr., Cordova B. 1991. IFN-induced 15-kDa protein is released from human lymphocytes and monocytes. J Immunol 146(7):2280-2284.
39. Knight E, Jr., Fahey D, Cordova B, Hillman M, Kutny R, Reich N, Blomstrom D. 1988. A 15-kDa interferon-induced protein is derived by COOH-terminal processing of a 17-kDa precursor. J Biol Chem 263(10):4520-4522.
40. Korant BD, Blomstrom DC, Jonak GJ, Knight E, Jr. 1984. Interferon-induced proteins. Purification and characterization of a 15, 000-dalton protein from human and bovine cells induced by interferon. J Biol Chem 259(23):14835-14839.
41. Kristiansen H, Scherer CA, McVean M, Iadonato SP, Vends S, Thavachelvam K, Steffensen TB, Horan KA, Kuri T, Weber F, Paludan SR, Hartmann R. 2010. Extracellular 2'-5' oli-goadenylate synthetase stimulates RNase L-independent an-tiviral activity: a novel mechanism of virus-induced innate immunity. J Virol 84(22):11898-11904.
42. Lacy P, Stow JL. 2011. Cytokine release from innate immune cells: association with diverse membrane trafficking pathways. Blood 118(1):9-18.
43. Lai C, Struckhoff JJ, Schneider J, Martinez-Sobrido L, Wolff T, Garcia-Sastre A, Zhang DE, Lenschow DJ. 2009. Mice lacking the ISG15 E1 enzyme UbE1 L demonstrate increased susceptibility to both mouse-Adapted and non-mouse-Adapted influenza B virus infection. J Virol 83(2):1147-1151.
44. Lenschow DJ, Giannakopoulos NV, Gunn LJ, Johnston C, O'Guin AK, Schmidt RE, Levine B, Virgin HW 4th. 2005. Identification of interferon-stimulated gene 15 as an antiviral molecule during Sindbis virus infection in vivo. J Virol 79(22):13974-13983.
45. Lenschow DJ, Lai C, Frias-Staheli N, Giannakopoulos NV, Lutz A, Wolff T, Osiak A, Levine B, Schmidt RE, Garcia-Sastre A, Leib DA, Pekosz A, Knobeloch KP, Horak I, Virgin HW 4th. 2007. IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc Natl Acad Sci USA 104(4):1371-1376.
46. Liu X, Wang Q, Chen W, Wang C. 2013. Dynamic regulation of innate immunity by ubiquitin and ubiquitin-like proteins. Cytokine Growth Factor Rev 24(6):559-570.
47. Loeb KR, Haas AL. 1992. The interferon-inducible 15-kDa ubiquitin homolog conjugates to intracellular proteins. J Biol Chem 267(11):7806-7813.
48. Loeb KR, Haas AL. 1994. Conjugates of ubiquitin cross-reactive protein distribute in a cytoskeletal pattern. Mol Cell Biol 14(12):8408-8419.
49. Lu G, Reinert JT, Pitha-Rowe I, Okumura A, Kellum M, Knobeloch KP, Hassel B, Pitha PM. 2006. ISG15 enhances the innate antiviral response by inhibition of IRF-3 degradation. Cell Mol Biol (Noisy-le-grand) 52(1):29-41.
50. MacKenzie A, Wilson HL, Kiss-Toth E, Dower SK, North RA, Surprenant A. 2001. Rapid secretion of interleukin-1beta by microvesicle shedding. Immunity 15(5):825-835.
51. Malakhov MP, Malakhova OA, Kim KI, Ritchie KJ, Zhang DE. 2002. UBP43 (USP18) specifically removes ISG15 from conjugated proteins. J Biol Chem 277(12):9976-9981.
52. Malakhova OA, Kim KI, Luo JK, Zou W, Kumar KG, Fuchs SY, Shuai K, Zhang DE. 2006. UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity. EMBO J 25(11):2358-2367.
53. Malakhova OA, Zhang DE. 2008. ISG15 inhibits Nedd4 ubi-quitin E3 activity and enhances the innate antiviral response. J Biol Chem 283(14):8783-8787.
54. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. 2002. Macrophage polarization: tumor-Associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23(11):549-555.
55. Merritt EA, Arakaki TL, Larson ET, Kelley A, Mueller N, Napuli AJ, Zhang L, Deditta G, Luft J, Verlinde CL, Fan E, Zucker F, Buckner FS, Van Voorhis WC, Hol WG. 2010. Crystal structure of the aspartyl-tRNA synthetase from En-tamoeba histolytica. Mol Biochem Parasitol 169(2):95-100.
56. Minakawa M, Sone T, Takeuchi T, Yokosawa H. 2008. Regulation of the nuclear factor (NF)-kappaB pathway by ISGylation. Biol Pharm Bull 31(12):2223-2227.
57. Morales DJ, Lenschow DJ. 2013. The antiviral activities of ISG15. J Mol Biol 425(24):4995-5008.
58. Naegelen I, Beaume N, Plancon S, Schenten V, Tschirhart EJ, Brechard S. 2015. Regulation of Neutrophil Degranulation and Cytokine Secretion: A Novel Model Approach Based on Linear Fitting. J Immunol Res 2015:817038.
59. Okumura A, Lu G, Pitha-Rowe I, Pitha PM. 2006. Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. Proc Natl Acad Sci USA 103(5):1440-1445.
60. Okumura A, Pitha PM, Harty RN. 2008. ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity. Proc Natl Acad Sci USA 105(10):3974-3979.
61. Okumura F, Okumura AJ, Uematsu K, Hatakeyama S, Zhang DE, Kamura T. 2013. Activation of double-stranded RNA-Activated protein kinase (PKR) by interferon-stimulated gene 15 (ISG15) modification down-regulates protein translation. J Biol Chem 288(4):2839-2847.
62. Owhashi M, Taoka Y, Ishii K, Nakazawa S, Uemura H, Kam-bara H. 2003. Identification of a ubiquitin family protein as a novel neutrophil chemotactic factor. Biochem Biophys Res Commun 309(3):533-539.
63. Padovan E, Terracciano L, Certa U, Jacobs B, Reschner A, Bolli M, Spagnoli GC, Borden EC, Heberer M. 2002. Inter-feron stimulated gene 15 constitutively produced by mela-noma cells induces e-cadherin expression on human dendritic cells. Cancer Res 62(12):3453-3458.
64. Park JH, Yang SW, Park JM, Ka SH, Kim JH, Kong YY, Jeon YJ, Seol JH, Chung CH. 2016. Positive feedback regulation of p53 transactivity by DNA damage-induced ISG15 modi-fication. Nat Commun 7:12513.
65. Pizzirani C, Ferrari D, Chiozzi P, Adinolfi E, Sandona D, Sa-vaglio E, Di Virgilio F. 2007. Stimulation of P2 receptors causes release of IL-1beta-loaded microvesicles from human dendritic cells. Blood 109(9):3856-3864.
66. Qu Y, Franchi L, Nunez G, Dubyak GR. 2007. Nonclassical IL-1 beta secretion stimulated by P2X7 receptors is dependent on inflammasome activation and correlated with exo-some release in murine macrophages. J Immunol 179(3): 1913-1925.
67. Rajkumar T, Sabitha K, Vijayalakshmi N, Shirley S, Bose MV, Gopal G, Selvaluxmy G. 2011. Identification and validation of genes involved in cervical tumourigenesis. BMC Cancer 11:80.
68. Recht M, Borden EC, Knight E, Jr. 1991. A human 15-kDa IFN-induced protein induces the secretion of IFN-gamma. J Immunol 147(8):2617-2623.
69. Rubartelli A, Cozzolino F, Talio M, Sitia R. 1990. A novel secretory pathway for interleukin-1 beta, a protein lacking a signal sequence. EMBO J 9(5):1503-1510.
70. Sadler AJ, Williams BR. 2007. Structure and function of the protein kinase R. Curr Top Microbiol Immunol 316:253-292.
71. Sainz B, Jr., Martin B, Tatari M, Heeschen C, Guerra S. 2014. ISG15 is a critical microenvironmental factor for pancreatic cancer stem cells. Cancer Res 74(24):7309-7320.
72. Schreiber G, Piehler J. 2015. The molecular basis for functional plasticity in type I interferon signaling. Trends Immunol 36(3):139-149.
73. Sheedy FJ, Grebe A, Rayner KJ, Kalantari P, Ramkhelawon B, Carpenter SB, Becker CE, Ediriweera HN, Mullick AE, Golenbock DT, Stuart LM, Latz E, Fitzgerald KA, Moore KJ. 2013. CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation. Nat Immunol 14(8):812-820.
74. Shi HX, Yang K, Liu X, Liu XY, Wei B, Shan YF, Zhu LH, Wang C. 2010. Positive regulation of interferon regulatory factor 3 activation by Herc5 via ISG15 modification. Mol Cell Biol 30(10):2424-2436.
75. Speer SD, Li Z, Buta S, Payelle-Brogard B, Qian L, Vigant F, Rubino E, Gardner TJ, Wedeking T, Hermann M, Duehr J, Sanal O, Tezcan I, Mansouri N, Tabarsi P, Mansouri D, Francois-Newton V, Daussy CF, Rodriguez MR, Lenschow DJ, Freiberg AN, Tortorella D, Piehler J, Lee B, Garcia-Sastre A, Pellegrini S, Bogunovic D. 2016. ISG15 deficiency and increased viral resistance in humans but not mice. Nat Commun 7:11496.
76. Srinivasula SM, Poyet JL, Razmara M, Datta P, Zhang Z, Al-nemri ES. 2002. The PYRIN-CARD protein ASC is an activating adaptor for caspase-1. J Biol Chem 277(24):21119-21122.
77. Sun L, Wang X, Zhou Y, Zhou RH, Ho WZ, Li JL. 2016. Exosomes contribute to the transmission of anti-HIV activity from TLR3-Activated brain microvascular endothelial cells to macrophages. Antiviral Res 134:167-171.
78. Takeuchi T, Yokosawa H. 2005. ISG15 modification of Ubc13 suppresses its ubiquitin-conjugating activity. Biochem Bio-phys Res Commun 336(1):9-13.
79. Tang Y, Zhong G, Zhu L, Liu X, Shan Y, Feng H, Bu Z, Chen H, Wang C. 2010. Herc5 attenuates influenza A virus bycatalyzing ISGylationofviralNS1 protein.JImmunol 184(10):5777-5790.
80. Thavachelvam K, Gad HH, Ibsen MS, Despres P, Hokland M, Hartmann R, Kristiansen H. 2015. Rapid Uptake and Inhibition of Viral Propagation by Extracellular OAS1. J In-terferon Cytokine Res 35(5):359-366.
81. Wong JJ, Pung YF, Sze NS, Chin KC. 2006. HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates type I IFN-induced ISGylation of protein targets. Proc Natl Acad Sci USA 103(28):10735-10740.
82. Wood LM, Pan ZK, Seavey MM, Muthukumaran G, Paterson Y. 2012. The ubiquitin-like protein, ISG15, is a novel tumor-Associated antigen for cancer immunotherapy. Cancer Im-munol Immunother 61(5):689-700.
83. Yang PM, Wang JT, Chiang BL, Lai MY, Chen DS. 1997. Serum 2', 5'-oligoadenylate synthetase concentrations in acute and chronic hepatitis C. J Formos Med Assoc 96(5):314-319.
84. Yao Y, Richman L, Higgs BW, Morehouse CA, de los Reyes M, Brohawn P, Zhang J, White B, Coyle AJ, Kiener PA, Jallal B. 2009. Neutralization of interferon-Alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-Alpha monoclonal antibody in systemic lupus erythematosus. Arthritis Rheum 60(6):1785-1796.
85. Yuan W, Krug RM. 2001. Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J 20(3):362-371.
86. ZengZ, Xu X, Zhang Y, Xing J, Long J, Gu L, WangX, Sun D, Ka W, Yao W, Wen Z, Chien S. 2007. Tumor-derived factors impaired motility and immune functions of dendritic cells through derangement of biophysical characteristics and reorganization of cytoskeleton. Cell Motil Cytoskeleton 64(3):186-198.
87. Zhang X, Bogunovic D, Payelle-Brogard B, Francois-Newton V, Speer SD, Yuan C, Volpi S, Li Z, Sanal O, Mansouri D, Tezcan I, Rice GI, Chen C, Mansouri N, Mahdaviani SA, Itan Y, Boisson B, Okada S, Zeng L, Wang X, Jiang H, Liu W, Han T, Liu D, Ma T, Wang B, Liu M, Liu JY, Wang QK, Yalnizoglu D, Radoshevich L, Uze G, Gros P, Rozenberg F, Zhang SY, Jouanguy E, Bustamante J, Garcia-Sastre A, Abel L, Lebon P, Notarangelo LD, Crow YJ, Boisson-Dupuis S, Casanova JL, Pellegrini S. 2015. Human intracellular ISG15 prevents interferon-Alpha/beta over-Amplification and auto-inflammation. Nature 517(7532):89-93.
88. Zhao C, Beaudenon SL, Kelley ML, Waddell MB, Yuan W, Schulman BA, Huibregtse JM, Krug RM. 2004. The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-Alpha/beta-induced ubiquitin-like protein. Proc Natl Acad Sci USA 101(20):7578-7582.
89. Zhao C, Denison C, Huibregtse JM, Gygi S, Krug RM. 2005. Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc Natl Acad Sci USA 102(29):10200-10205.
90. Zhao C, Hsiang TY, Kuo RL, Krug RM. 2010. ISG15 conjugation system targets the viral NS1 protein in influenza A virus-infected cells. Proc Natl Acad Sci USA 107(5):2253-2258.
91. Zou W, Kim JH, Handidu A, Li X, Kim KI, Yan M, Li J, Zhang DE. 2007. Microarray analysis reveals that Type I interferon strongly increases the expression of immune-response related genes in Ubp43 (Usp18) deficient macrophages. Biochem Biophys Res Commun 356(1):193-199.